Sign In
Buy BMY
$54.72
+0.260 (+0.477%)
At Close: Jun 03, 2026
Cary Street Partners Financial LLC Increases Stake in Bristol Myers Squibb Company $BMY
04:34am, Thursday, 26'th Feb 2026
Cary Street Partners Financial LLC grew its stake in Bristol Myers Squibb Company (NYSE: BMY) by 11.6% during the undefined quarter, according to the company in its most recent filing with the Securit
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock
10:41am, Wednesday, 25'th Feb 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
5 Very Safe High-Yield Dividend Stocks Boomers Can Hold Forever
09:16am, Wednesday, 25'th Feb 2026
While many Baby Boomers have enjoyed a long bull market over the past 35 years, there is a point when income becomes more critical than stock appreciation.
NYSE Content Update: Two MSCI Indexes to Begin Trading on NYSE Arca Options
08:55am, Wednesday, 25'th Feb 2026
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Feb. 25, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the N
First Financial Bankshares Inc Takes Position in Bristol Myers Squibb Company $BMY
05:02am, Wednesday, 25'th Feb 2026
First Financial Bankshares Inc acquired a new position in shares of Bristol Myers Squibb Company (NYSE: BMY) in the third quarter, according to its most recent Form 13F filing with the SEC. The firm a
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
10:00am, Tuesday, 24'th Feb 2026
Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.
Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference
04:16pm, Monday, 23'rd Feb 2026
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (α)-Thalassemia.
Citigroup Inc. Lowers Stock Position in Bristol Myers Squibb Company $BMY
04:46am, Sunday, 22'nd Feb 2026
Citigroup Inc. reduced its position in Bristol Myers Squibb Company (NYSE: BMY) by 30.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission.
Down 25%, Should You Buy the Dip on Bristol Myers Squibb?
02:00pm, Saturday, 21'st Feb 2026
Multiple core drugs are losing patent protection over the coming years, carving an eventual crater in revenue. Newer, growing drugs should help fill that hole, and Cobenfy is a wild card with huge pot
Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026?
01:06pm, Friday, 20'th Feb 2026
BMY edges past MRK as generic headwinds bite, but new drug launches, cost cuts and a stronger 2026 outlook tilt the investment case in its favor.
Pre-Market Stock Futures: Futures are trading lower as we wrap up the holiday-shortened week that gave us a little taste of just about everything. While Walmart posted results that beat expectations,
2 Incredibly Cheap Dividend Stocks to Buy Now
04:41pm, Thursday, 19'th Feb 2026
A crucial oil and gas infrastructure company has a stock with a 5.9% yield on its dividend. A veteran pharmaceutical giant pays out a dividend yielding a generous 4.2%.
Bristol-Myers: I'm Buying Post Earnings
04:09pm, Thursday, 19'th Feb 2026
Bristol-Myers: I'm Buying Post Earnings
3 Stocks to Buy and Hold for 2026 and Beyond
12:15pm, Thursday, 19'th Feb 2026
AbbVie is a Dividend King, poised for strong growth with Rinvoq and Skyrizi. Eli Lilly has taken control of the obesity drug market, with major possibilities ahead.
